At the Crossroad of Care: New Advances in Diabetic Kidney Disease - a podcast by ReachMD

CME credits: 0.50

Valid until: 28-01-2022

Claim your CME credit at https://reachmd.com/programs/cme/at-the-crossroad-of-care-new-advances-in-diabetic-kidney-disease/12092/

Type 2 diabetes mellitus (T2DM) represents the main cause of chronic kidney disease and end-stage renal disease, accounting for almost 50 percent of all patients starting renal replacement therapy worldwide. At least half of the patients with T2DM will develop diabetic kidney disease (DKD). DKD is the single strongest predictor of morbidity and premature mortality in patients with diabetes. Even mild increases in albuminuria or GFR decline are associated with an increased risk of cardiovascular diseases and CV death, along with increased health-care costs. Therefore, kidney protection is a critical target in T2DM. Join us as we take a look at new therapeutic agents for the prevention of DKD development and progression.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD